Today: 19 June 2026
Browse Category

Earnings Reports 10 January 2026

Kroger maintained its 2026 outlook after first-quarter sales exceeded forecasts, but adjusted earnings missed estimates by a cent. Shares fell in premarket trading due to margin pressure from price investments, higher transport costs, and changes in fuel mix. CarMax reported fiscal Q1 revenue of $8.01 billion, beating forecasts, driven by higher used-car prices and strong wholesale demand, though retail used-vehicle gross profit per unit declined and the company continued price cuts to boost sales. La-Z-Boy shares rebounded nearly 17% in after-hours trading after adjusted earnings beat expectations, with revenue flat year-over-year; retail expansion supported results, but same-store orders and Joybird sales remained weak. Micron Technology shares dropped 3.6% after a record close as semiconductor stocks slipped, with investors locking in profits rather than reacting to specific company news. Netflix shares declined amid deal speculation involving Roku and Lionsgate, with the next earnings date set for July 16; the stock’s outlook depends on ads, pricing, and engagement. AT&T shares dipped 1.23% before a slight premarket uptick, underperforming the broader market as telecom stocks were influenced more by rate changes than company news; its Q2 earnings call is upcoming. Dave & Buster’s shares fell 4.72% after earnings missed on revenue, profit, and comps, raising questions about future sales and free-cash-flow targets. Nokia shares dropped 3.32% in Helsinki after a recent surge, with its ADR slightly up in New York; the company is set to report soon. Ford shares lagged the S&P 500, with the company seeking to continue importing China-built Lincoln Nautilus as new U.S. rules for connected-car software approach.
Alibaba stock slides as China probes food-delivery price war; BABA investors eye Feb. 19 earnings

Alibaba stock slides as China probes food-delivery price war; BABA investors eye Feb. 19 earnings

Alibaba’s U.S.-listed shares fell 2.3% to $150.96 on Friday after China announced a probe into competition among food-delivery platforms, including Alibaba. The drop followed a 5.7% gain the previous day. Traders cited regulatory scrutiny and AI chip supply updates as key factors. Alibaba’s next earnings report is scheduled for Feb. 19.
AbbVie stock slips into weekend after $1.3 billion charge resets guidance; JPM conference looms

AbbVie stock slips into weekend after $1.3 billion charge resets guidance; JPM conference looms

AbbVie shares fell 1.8% to $220.08 Friday after the company cut its Q4 and 2025 profit forecasts, citing a $1.3 billion charge for acquired R&D and milestone expenses. The company denied rumors of takeover talks with Revolution Medicines. AbbVie will present at the J.P. Morgan Healthcare Conference on Jan. 14 and report earnings on Feb. 4.
ASML stock leaps 7% as TSMC revenue beat lifts chip gear names into CPI, earnings week

ASML stock leaps 7% as TSMC revenue beat lifts chip gear names into CPI, earnings week

ASML shares surged 6.7% to $1,273.88 Friday, leading a semiconductor rally that sent the Philadelphia SE Semiconductor Index to a record high. TSMC reported fourth-quarter revenue up 20.45% year-on-year, beating forecasts ahead of its Jan. 15 guidance update. Investors await the U.S. CPI release on Jan. 13 and ASML’s earnings on Jan. 28. Markets closed flat overall.
Samsung Electronics stock clings to 139,000 won after record profit guide — what matters before Jan 29

Samsung Electronics stock clings to 139,000 won after record profit guide — what matters before Jan 29

Samsung Electronics shares closed Friday at 139,000 won, up 0.1%. The company forecast Q4 operating profit near 20 trillion won, a sharp jump from 12.17 trillion won in Q3. Investors await the Jan. 29 earnings call for details on memory and margin pressures. DRAM prices surged over 30% quarter-on-quarter, fueling expectations for further gains.
Broadcom stock jumps after Mizuho lifts target; CPI week sets up next test for AVGO

Broadcom stock jumps after Mizuho lifts target; CPI week sets up next test for AVGO

Broadcom shares jumped 3.7% to $344.97 Friday, lifting the PHLX Semiconductor Index to a record. Mizuho raised its price target on Broadcom to $480, citing “attractive valuations.” Cathie Wood’s ARK Invest bought 31,573 shares, while Broadcom’s legal chief sold 30,000 shares. The stock remains 17% below its 52-week high after a December warning on profit margins.
Netflix stock slips as Paramount challenges Warner deal; CPI and earnings are next

Netflix stock slips as Paramount challenges Warner deal; CPI and earnings are next

Paramount Skydance reaffirmed its $108.4 billion bid for Warner Bros. Discovery, topping Netflix’s $72 billion offer. Netflix shares fell 1.2% to $89.46. Netflix co-CEO Greg Peters received 207,420 shares as performance-based stock units vested. Investors await U.S. inflation data Jan. 13 and Netflix’s fourth-quarter earnings Jan. 20.
Lam Research stock jumps on Mizuho target hike as chip-tool rally sets up next earnings test

Lam Research stock jumps on Mizuho target hike as chip-tool rally sets up next earnings test

Lam Research shares surged 8.7% to $218.36 Friday after Mizuho raised its price target and the PHLX chip index hit a record. Heavy trading snapped a two-day slide for Lam, which will report earnings Jan. 28. Applied Materials and KLA also posted strong gains. Traders are watching next week’s U.S. inflation data and the Fed’s policy meeting for signals on rate cuts.
GSK stock: $50m Noetik deal and Jemperli royalty lawsuit sharpen focus on Feb 4 results

GSK stock: $50m Noetik deal and Jemperli royalty lawsuit sharpen focus on Feb 4 results

AnaptysBio filed a motion to dismiss part of GSK’s claim in a Delaware court dispute over royalties from cancer drug Jemperli. The court is expected to hear the motion by early March, with trial set for July. GSK ADRs closed up 0.3% at $50.39 in New York; London shares slipped 0.26% to 1,886 pence. Investors await GSK’s Jan. 13 conference appearance and Feb. 4 results.
Keppel Ltd stock: Feb. 5 results date is set — here’s what traders watch next

Keppel Ltd stock: Feb. 5 results date is set — here’s what traders watch next

Keppel Ltd will release its second-half and full-year 2025 results on Feb. 5, after three Keppel-sponsored REITs report from Jan. 30. Keppel shares closed Friday down 0.7% at S$10.47, trading near a 52-week high. About 2.06 million shares changed hands, with S$10.46 as support and S$10.56 as resistance. All financial releases will be made before market open, the company said.
South32 stock near a 2026 high as dividend dates land; traders eye Feb 12 results

South32 stock near a 2026 high as dividend dates land; traders eye Feb 12 results

South32 shares closed up 1.1% at A$3.85, just below their 2026 high, after the miner released its 2026 calendar and set Feb. 12 for half-year results. The company confirmed a March 5 ex-dividend date and flagged a $60 million cost for the Mozal smelter shutdown in Mozambique. The S&P/ASX 200 slipped 0.03% as Rio Tinto fell 6.2%. Glencore shares surged over 10% on takeover talks with Rio Tinto.
1 154 155 156 157 158 257

Stock Market Today

  • Credo Technology Group Holding (CRDO) Stock Seen 109.1% Overvalued After Strong Price Rally
    June 18, 2026, 9:56 PM EDT. Credo Technology Group Holding (CRDO) stock surged 162.89% over three months, reaching a high of $271.83 per share. Despite strong momentum and a 3-year return exceeding 10 times initial value, analysts at Simply Wall St rate the stock as 109.1% overvalued with a fair value of $130.00. This significant gap reflects market expectations for future growth in AI connectivity and product pipelines priced into shares. While profitability remains solid, risks include delays in product launches through 2027-28 and shifts in AI infrastructure spending. Investors are urged to weigh the company's rapid growth against these uncertainties before investing.

Latest articles

Kardigan pops in first Nasdaq trading after $400 million IPO

Kardigan pops in first Nasdaq trading after $400 million IPO

19 June 2026
Kardigan surged 37.5% above its $16 IPO price to close at $22 after raising $400 million in an upsized Nasdaq debut, signaling renewed investor appetite for large biotech IPOs as the company advances three late-stage cardiovascular drug candidates.
Go toTop